Jonathan Shaw in Harvard Magazine:
Not infrequently, companies lure professors to highly paid positions directing scientific research in pharmaceuticals, technology, and related fields. But the recent departures of some leading Harvard scientists deeply committed to improving human health point to a different phenomenon: challenges to conducting translational life-sciences research in academic settings. Given the University’s emphasis on and investment in the life sciences and biomedical discovery, these scientists’ differing decisions suggest emerging issues and concerns about current constraints and the future of such research.
Applying for National Institutes of Health (NIH) grants can take a substantial portion of an investigator’s time, and as much as a year can pass between a submission deadline and the point when funds are received and disbursed by the recipient’s home institution.
More here.
Enjoying the content on 3QD? Help keep us going by donating now.